The PROSEEK trial of KO706

Sun Pharma Advanced Research Company (SPARC) is conducting a phase 2 clinical trial to evaluate the safety and effectiveness of its experimental c-Abl inhibitor KO706 in people with early Parkinson’s.


News Fundraising news

Patron Paul Mayhew-Archer raises over £10k for Cure Parkinson’s and Maggie’s Cancer Centres

Arabella Slinger from London, will set off to complete this extreme and gruelling challenge in support of Parkinson’s research.


News Fundraising news

First British woman to ski Amundsen’s route to the South Pole takes on the challenge for Cure Parkinson’s

Arabella Slinger from London, will set off to complete this extreme and gruelling challenge in support of Parkinson’s research.


NECTAR 2021

The Network for European CNS Transplantation and Restoration (NECTAR) was founded over 25 years ago. Here, Dr Simon Stott presents a brief update on the events at NECTAR 2021.


News Research news

Post-hoc analyses of the isradipine and nilotinib trial results

Results from major Parkinson’s clinical trials, of the blood pressure medication isradipine and the cancer treatment nilotinib, found that these drugs had no effect on the progression of the disease. Now, post-hoc analyses of the trial data have identified some interesting results that may deserve…